Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200

被引:23
|
作者
Li, ZH
Zhu, YJ
Lit, XT
机构
[1] CHINESE ACAD MED SCI, INST CANC, DEPT PHARMACOL, BEIJING 100021, PEOPLES R CHINA
[2] BEIJING UNION MED COLL, BEIJING 100021, PEOPLES R CHINA
[3] CHINESE ACAD MED SCI, INST CANC, DEPT BIOCHEM, BEIJING 100021, PEOPLES R CHINA
基金
中国国家自然科学基金;
关键词
p53; gene; MDR1; drug resistance; anticancer drug; apoptosis;
D O I
10.1016/S0304-3835(97)00267-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of p53 gene and overexpression of MDR1 gene are both associated with drug resistance, Previous studies have suggested that p53 gene can modulate the expression activity of MDR1 gene promoter in a promoter-CAT system. In the present study, wild-type p53 gene cDNA was introduced into a multidrug-resistant cell line, KBV200, in which endogenous p53 gene is aberrant. In wt-p53 transfected cells, the expression of MDR1 gene was significantly increased, accumulation of adriamycin (ADM) was decreased, and the sensitivity to vincristine (VCR), ADM and 5-fluorouracil (5-FU) was increased compared with the parent KBV200 cells, After treatment with ADM and VCR, the p53-transfectants were more susceptible to apoptosis. The results suggest that the increase in drug sensitivity of the cells may be, at least in part, due to p53-dependent apoptosis induced by anticancer agents. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [1] Wild-type p53 binds to the human MDR1 promoter
    Strauss, BE
    Haas, M
    FASEB JOURNAL, 1999, 13 (07): : A1480 - A1480
  • [2] MDR1 gene expression and drug resistance of AML cells
    Norgaard, JM
    Bukh, A
    Langkjer, ST
    Clausen, N
    Palshof, T
    Hokland, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (03) : 534 - 540
  • [3] SUPPRESSION OF THE HUMAN MDR1 DOWNSTREAM PROMOTER BY WILD-TYPE AND MUTANT HUMAN P53
    STRAUSS, BE
    HAAS, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 182 - 182
  • [4] P53 GENE MUTATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS ASSOCIATED WITH DRUG-RESISTANCE AND IS INDEPENDENT OF MDR1/MDR3 GENE-EXPRESSION
    ELROUBY, S
    THOMAS, A
    COSTIN, D
    ROSENBERG, CR
    POTMESIL, M
    SILBER, R
    NEWCOMB, EW
    BLOOD, 1993, 82 (11) : 3452 - 3459
  • [5] Modulation of MDR/MRP by wild-type and mutant p53
    Bähr, O
    Wick, W
    Weller, M
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 643 - 645
  • [6] TRANSACTIVATION OF THE HUMAN MULTIDRUG-RESISTANCE (MDR1) GENE PROMOTER BY P53 MUTANTS
    NGUYEN, KT
    LIU, BR
    UEDA, K
    GOTTESMAN, MM
    PASTAN, I
    CHIN, KV
    ONCOLOGY RESEARCH, 1994, 6 (02) : 71 - 77
  • [7] MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53
    CHIN, KV
    UEDA, K
    PASTAN, I
    GOTTESMAN, MM
    SCIENCE, 1992, 255 (5043) : 459 - 462
  • [8] EXPRESSION OF THE MULTIDRUG RESISTANCE, MDR1, GENE IN NEUROBLASTOMAS
    GOLDSTEIN, LJ
    FOJO, AT
    UEDA, K
    CRIST, W
    GREEN, A
    BRODEUR, G
    PASTAN, I
    GOTTESMAN, MM
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) : 128 - 136
  • [9] The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53
    Strauss, BE
    Shivakumar, C
    Deb, SP
    Deb, S
    Haas, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 217 (03) : 825 - 831
  • [10] Drug resistance and MDR1 gene expression of AML blast cells.
    Norgaard, JM
    Bukh, A
    Palshof, T
    Hokland, P
    BLOOD, 1997, 90 (10) : 3649 - 3649